Cognitive impairment in probable multiple sclerosis

Journal of Neurology Neurosurgery and Psychiatry

Volumn 74, Issue 4, 2003, Pages 443-446

  Achiron, A ^a   Barak, Y ^b  

^a SHEBA MEDICAL CENTER   (Israel)

^b ABARBANEL MENTAL HEALTH CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; ARTICLE; ATTENTION; BRAIN; CALCULATION; COGNITIVE DEFECT; CORRELATION COEFFICIENT; DISEASE CLASSIFICATION; EVALUATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFORMANCE; PRIORITY JOURNAL; SYMPTOM; VALIDATION PROCESS; VERBAL BEHAVIOR;

ADOLESCENT; ADULT; BRAIN; COGNITION DISORDERS; DISABILITY EVALUATION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 0037379848     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.74.4.443     Document Type: Article

References (31)

1. Achiron A, Barak Y. Multiple sclerosis - from probable to definite diagnosis. A 7-year prospective study. Arch Neurol 2000;57:974-9.
2. Paty DW. Magnetic resonance in multiple sclerosis. Curr Opin Neurol Neurosurg 1993;6:202-8.
3. Filippi M, Horsfield MA, Morrissey SP, et al. Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis. Neurology 1994;44:635-41.
4. Pelosi L, Geesken JM, Holly M, et al. Working memory impairment in early multiple sclerosis. Evidence from an event-related potential study of patients with clinically isolated myelopathy. Brain 1997;120:2039-58.
5. Ron MA, Feinstein A. Multiple sclerosis and the mind. J Neurol Neurosurg Psychiatry 1992;55:1-3.
6. Kesselring J, Klement U. Cognitive and affective disturbances in multiple sclerosis. J Neurol 2001;248:180-3.
7. Grant I, McDonald WI, Trimble MR, et al. Deficient learning and memory in early and middle phases of multiple sclerosis. J Neurol Neurosurg Psychiatry 1984;47:250-5.
8. Zivadinov R, Sepcic J, Nasuelli D, et al A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 2001;70:773-80.
9. Schwid SR, Bever CT. The cost of delaying treatment in multiple sclerosis. What is lost is not regained. Neurology 2001;56:1620.
10. DeStefano N, Narayanan S, Francis GS, et al. Evidence of axonal damoge in the early stages of multiple sclerosis and its relevance to disability. Arch Neurol 2001;58:65-70.
11. Bjartmar C, Kidd G, Ransohoff RM. A real-time insight into disease progression and the role of axonal injury in multiple sclerosis. Arch Neurol 2001;58:37-9.
12. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-31.
13. Fazekas F, Barkhof F, Filippi M, et al. The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis. Neurology 1999;53:448-56.
14. Bever CT Jr, Grattan L, Panitch HS, et al. The Brief Repeatable Battery of Neuropsychological Tests for Multiple Sclerosis: a preliminary serial study. Mult Scler 1995;1:165-9.
15. Boringa JB, Lazeron RHC, Reuling IEW, et al. The Brief Repeatable Battery of Neuropsychological Tests: normative values allow application in multiple sclerosis clinical practice. Mult Scler 2001;7:263-7.
16. Barak Y, Achiron A. The effect of interferon-beta-1B (IFN-b) on cognitive function in multiple sclerosis. Eur Neurol 2002;47:11-14.
17. Shulman KI, Gold DP, Cohen CA, et al. Clock-drawing and dementia in the community: a longitudinal study. Int J Geriatric Psychiatry 1993;8:487-96.
18. Royall DR, Mulroy AR, Chiodo LK, et al. Clock drawing is sensitive to executive control: a comparison of six methods. J Gerontol B Psychol Sci Soc Sci 1999;54:328-33.
19. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983;33:1444-52.
20. Barak Y, Gabbay U, Gilad R, et al. Neuropsychiatric assessment as a secondary outcome measure in a multiple sclerosis IVIg trial. Int J Psychiatry Clin Pract 1999;3:31-4.
21. Stern M, Gicquel S, Miron S, et al. Three dimensional brain MR imaging of multiple sclerosis lesions: development of a new image processing software. Mult Scler 2001;7(suppl 1):S91.
22. Fischer JS, Priore RL, Jacobs LD, et al, and the Multiple Sclerosis Collaborative Research Group. Neuropsychological effects of interferon b-1a in relapsing multiple sclerosis. Ann Neurol 2000;48:885-92.
23. Rao SM, Leo GJ, Bernardin L, et al. Cognitive dysfunction in multiple sclerosis 1. Frequency, patterns and prediction. Neurology 1991;41:685-91.
24. Brassington JC, Marh NV. Neuropsychological aspects of multiple sclerosis. Neuropsychol Rev 1998;8:43-77.
25. Lyon-Caen O, Jouvent R, Hauser S, et al. Cognitive functions in recent, onset demyelinating diseases. Arch Neurol 1986;43:1138-41.
26. Callanan MM, Logsdail SG, Ron MA, et al. Cognitive impairment in patients with clinically isolated lesions of the type seen in multiple sclerosis. Brain 1989;112:361-74.
27. Feinstein A, Kartsounis LD, Miller DH, et al. Clinically isolated lesions of the type seen in multiple sclerosis: a cognitive psychiatric and MRI follow up study. J Neurol Neurosurg Psychiatry 1992;55:869-76.
28. Hohol MJ, Guttmann CR, Orav J, et al. Serial neuro-psychological assessment and mognetic resonance imaging analysis in multiple sclerosis. Arch Neurol 1997;54:1018-25.
29. Feinstein A, Ron M, Thompson A. A serial study of psychametric and magnetic resonance imaging in multiple sclerosis. Brain 1993;116:569-602.
30. Rovaris M, Filippi M, Falautano M, et al. Relation between MR abnormalities and patterns of cognitive impairment in mutiple sclerosis. Neurology 1999;50:1601-8.
31. Trapp BD, Peterson J, Ransohoff RM, et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998;338:278-85.